These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18049445)

  • 1. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
    Das UN
    Med Sci Monit; 2007 Dec; 13(12):RA214-21. PubMed ID: 18049445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease.
    Rao AA; Sridhar GR; Das UN
    Med Hypotheses; 2007; 69(6):1272-6. PubMed ID: 17553629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of metabolic syndrome X and its links to the perinatal period.
    Das UN
    Nutrition; 2005 Jun; 21(6):762-73. PubMed ID: 15925303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
    Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
    Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
    Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
    J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
    Mesulam M; Guillozet A; Shaw P; Quinn B
    Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis.
    Rojas-Rodríguez J; Escobar-Linares LE; Garcia-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Zamora-Ustaran A
    Med Hypotheses; 2007; 69(4):860-8. PubMed ID: 17368954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of distigmine bromide on the central cholinergic system.
    Nakayama K; Katsu H; Kitazumi K
    J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner.
    Schallreuter KU; Elwary S
    Life Sci; 2007 May; 80(24-25):2221-6. PubMed ID: 17335854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation.
    Brenner T; Nizri E; Irony-Tur-Sinai M; Hamra-Amitay Y; Wirguin I
    J Neuroimmunol; 2008 Sep; 201-202():121-7. PubMed ID: 18684515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified human plasma glycosaminoglycans reduced NF-kappaB activation, pro-inflammatory cytokine production and apoptosis in LPS-treated chondrocytes.
    Campo GM; Avenoso A; Campo S; D'Ascola A; Traina P; Samà D; Calatroni A
    Innate Immun; 2008 Aug; 14(4):233-46. PubMed ID: 18669609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
    Chiou SY; Wu YG; Lin YF; Lin LY; Lin G
    J Biochem Mol Toxicol; 2007; 21(1):24-31. PubMed ID: 17366539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats.
    Kalayarasan S; Prabhu PN; Sriram N; Manikandan R; Arumugam M; Sudhandiran G
    Eur J Pharmacol; 2009 Mar; 606(1-3):162-71. PubMed ID: 19374873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
    Darvesh S; McDonald RS; Darvesh KV; Mataija D; Conrad S; Gomez G; Walsh R; Martin E
    Bioorg Med Chem; 2007 Oct; 15(19):6367-78. PubMed ID: 17681768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
    Cerbai F; Giovannini MG; Melani C; Enz A; Pepeu G
    Eur J Pharmacol; 2007 Oct; 572(2-3):142-50. PubMed ID: 17643410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-mediated inflammation in adipose tissue does not cause insulin resistance in hyperlipidemic mice.
    Sultan A; Strodthoff D; Robertson AK; Paulsson-Berne G; Fauconnier J; Parini P; Rydén M; Thierry-Mieg N; Johansson ME; Chibalin AV; Zierath JR; Arner P; Hansson GK
    Circ Res; 2009 Apr; 104(8):961-8. PubMed ID: 19299644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of butyrylcholinesterase in vivo in horses by the feed-through larvacide Equitrol.
    Karanth S; Holbrook T; MacAllister C; Pope CN
    Regul Toxicol Pharmacol; 2008 Mar; 50(2):200-5. PubMed ID: 18166255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.